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Standard neurobehavioral evaluation
Prior to the assessment of neurocognitive functions, information regarding participants' medical, social and occupational history was obtained through a basic demographic inventory, administered via an interview format. Depressive complaints, cognitive complaints, and Independence in Activities of Daily Living (IADL) were assessed with standard self-report instruments (Beck Depression Inventory-II [1, 2] , Personal Assessment of Own Functioning Inventory [3] and IADL [4] ). Antiretroviral medication adherence was also recorded using a questionnaire was adapted from [5] recommendations. The neurobehavioral examination also included a brief neuropsychiatric semi-structured interview (Electronic Mini International Neuropsychiatric Interview -eM.I.N.I version 5.2 [6] ). On this examination, we found that 11% of the HIV+ participant had experienced a major depressive episode. As per design, no participants were found to have current substance abuse or dependence disorders. All participants underwent a standard neuropsychological evaluation to assess functions of attention/working memory; verbal learning and memory, verbal generativity; fine-motor coordination; mental flexibility/inhibition and speed of information processing (See Table S1 for individual tests). The session duration was approximately two hours.
The standard neuropsychological testing was conducted by research assistants/students who were neuro/psychology graduates (EF, TL and DM were trained in the administration of the testing protocol under the supervision of a senior neuropsychologist, LAC). All measures were administered and scored according to standard procedures. Neuropsychological scores were converted into demographically corrected T-scores and deficit scores to compute overall impairment rate and domain specific performance scores Carey et al., 2004) . Using published normative data [7, 8] , raw scores were converted to demographically corrected T-scores in order to minimize the influence as appropriate of age, education, sex and ethnicity (Caucasians versus other). T-scores were then transformed into a Global Deficit Score (GDS, [9] ) according to the following criteria: T-scores greater than 40 reflects no impairment (deficit score = 0), whereas a deficit score of 1 reflects mild impairment (T score = 39 to 35), deficit score of 2 reflects mild to moderate impairment (T score = 34 to 30), 3 reflects moderate impairment (T score = 29 to 25), 4 reflects moderate to severe impairment (T score = 24 to 20), and 5 reflects severe impairment (T score <20). Deficit scores on all tests were averaged to create the GDS. A GDS ≥ 0.5 a clinically validated and reliable cutoff [9] which indicates that, on average, an individual is at least mildly impaired in at least half the single neuropsychological measure in the battery (the current battery was composed of 16 neuropsychological measures). 
Right Caudate Nucleus / Basal ganglia
Voxel was positioned as much as possible within the right caudate nucleus. When severe atrophy was present the voxel was positioned in the basal ganglia.
Rationale for voxel selection
The frontal white matter has been systematically studied in the cART era neuroHIV studies and abnormalities related to age and HIV infection have been found (see introduction). The caudate nucleus was selected rather than other basal ganglia nuclei based on a review by Paul et al. [15] which has identified that the caudate nuclei are a primary target of HIV infection. The posterior cingulate cortex has been systematically used in normal aging and pathological aging studies (see introduction).
Rationale for unsuppressed water signal (H 2 O) as the main reference
We used the unsuppressed water signal (H 2 O) as the main reference rather than Creatine. There is now cumulative evidence that Creatine is not constant across brain region including in nonpathological state such as normal aging for example. The use of H 2 O as the reference marker is now advocated as an alternative except when water variations are expected in certain clinical 7 conditions. To gain specific understanding on the use of H 2 O as the reference and the associated MRS protocols we recommend the textbook by Barker, et al. [16] . 
Spectra illustrations
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Tonometry examination procedure HIV+ participants underwent non-invasive tonometry to estimate arterial stiffness of the radial artery. Pulse pressure was used as research indicated that it is a better predictor of cardiac ischemic events than systolic, diastolic, or mean brachial pressures [17] . The evaluation was performed in duplicate by a single operator at the left radial artery using a highly sensitive transducer (SphygmoCor, AtCor Medical, Sydney). An augmentation index was calculated by dividing the difference between the second systolic peak and the diastolic pressure by the difference between the first systolic peak and the diastolic pressure and expressed as a percentage. Systolic blood pressure was also recorded at this time.
Extra Results section Neurocognitive and mood and functional characteristics in study groups
The HIV+ individuals as a group showed a significantly greater degree of overall neurocognitive impairment (Table S2) . We found that 23% of HIV+ participants had clinically relevant (GDS≥0.5) level of neuropsychological (NP) deficits or HAND. Cognitive complaints were significantly more frequent in the HIV+ group than the HIV-group. While the HIV+ group also had a mild level of depressive complaints, the HIV+ individuals who reported clinically significant levels of depressive complaints (16%; BDI-II total score > 17) were no more likely to be NP impaired than those who did not (p>.27). Almost a quarter of the HIV+ cohort selfreported a decrease in independence in activities of daily living. Furthermore, those who reported clinically significant decline activities of daily living were more likely to have HAND as 4. BDI-II clinically significant: A cut off of >17 was used to define clinically significant levels of depression.
Note that there was no significant correlation between the CVD scores and the global neuropsychological performance.
